QQ客服 官方微博 反馈留言

	PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway
	Liu Y.; Qu Y.; Liu L.; Zhao H.; Ma H.; Si M.; Cheng L.; Nie L.
刊名	International Immunopharmacology
	2019
卷号	72页码:138-147
关键词	Inflammatory Interleukin-17 Intervertebral disc degeneration NF-κB pathway PPAR-γ TNF-α
DOI	10.1016/j.intimp.2019.04.012
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4548716
专题	山东大学
作者单位	1.Department of Orthopedics, Qilu Hospital of Shandong University, Jinan, China 2.Department of the Hand Surgery, the Second Hospital of
推荐引用方式 GB/T 7714	Liu Y.,Qu Y.,Liu L.,et al. PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway[J]. International Immunopharmacology,2019,72:138-147.
APA	Liu Y..,Qu Y..,Liu L..,Zhao H..,Ma H..,...&Nie L..(2019).PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway.International Immunopharmacology,72,138-147.
MLA	Liu Y.,et al."PPAR-γ agonist pioglitazone protects against IL-17 induced intervertebral disc inflammation and degeneration via suppression of NF-κB signaling pathway".International Immunopharmacology 72(2019):138-147.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。